Register Now for PHA's 2023 Innovation Summit: Decision Makers Connect |
|
The Population Health Alliance (PHA) is holding a distinctive in person event “PHA23 Innovation Summit "Decision Makers Connect” in Washington, D.C. October 25-26 at the Top of the Hill Conference Center. As the only Population Health Improvement professional and trade event, the summit will focus on marketplace needs that improve the consumer journey and health, achieve quality of care targets, reduce costs and advance technologies to improve efficiency and relieve burdens from an already stretched workforce. The intimate environment will allow you to meet directly with senior leadership colleagues that are your existing and future business partners. For a complete agenda, list of speakers, networking events and registration, visit our summit website and be sure to take advantage of the early bird registration rate, which ends August 31, and save anywhere from $100-$300!
|
|
Featured PHA Innovation Summit Speaker of the Month |
|
Digital health is vital to transform how we access, deliver and manage healthcare. As a leader in engagement, PHA Member, Vitality, is at the forefront of innovating to improve the health and wellbeing of individuals globally. Be sure to attend PHA's Innovation Summit and hear the keynote session by PHA Board of Directors Member and Vitality USA’s CEO, Maia Surmava, as she explores the critical role of digital health in the evolving healthcare landscape and how it is transforming the healthcare industry.
Maia will delve into various aspects of digital health and examine how they are being used to improve outcomes and transform healthcare consumer experience. Her session will also touch on digital health adoption challenges, such as data privacy and security concerns, and how Vitality and the industry are stepping up to address them. The audience will leave with a better understanding of the role of digital health and how they can leverage it to innovate and improve outcomes.
|
|
Thank You to PHA's Innovation Summit Sponsors |
|
Now is the Time to Make the Most of your Presence at PHA's 2023 Innovation Summit |
|
For information about sponsorship opportunities, please review our
|
|
"Medicaid Redetermination-Continuity of Eligibility and Care for Vulnerable Members"
Presented by PHA in Collaboration with Sellers Dorsey
|
|
If you weren't able to join us live for this webinar, you can listen to the recording and access the whitepaper and handouts by visiting PHA's website.
Held on May 11th, this webinar reviewed the findings in the compelling new issue brief recently published by Population Health Alliance (PHA) and Sellers Dorsey, which examined the Medicaid Redetermination and the critical importance of Continuous Medicaid eligibility that has been in place since the Families First Coronavirus Response Act (FFCRA) of 2020. The one-hour webinar shared perspectives from our panelists of industry experts regarding their efforts to assist and also highlight the health and fiscal impacts and opportunities to maintain coverage and continuity of care for individuals as set forth in our Issue Brief.
Attendees heard from PHA Board Director and Chair of PHA's Medicaid Continuity & Quality Workgroup, Bill Lucia, and Co-Chair Leesa Allen, Managing Director of Sellers Dorsey and former Department of Human Services Executive Deputy Secretary and Medicaid Director for the Commonwealth of Pennsylvania, in addition to our panel experts; David Grant, Chief Operating Officer of Keystone Health, along with Dr. Anthony Akosa with Franciscan Alliance, and Cheryl Friedman, Senior Vice President of Healthcare Services/Population Health with Independent Health.
"This is an unprecedented time for Medicaid and the organizations that support this vital program. It is in all stakeholders’ interest to assure continuity of coverage and care, avoiding unnecessary increases in cost and poor outcomes for this vulnerable population,” said Bill Lucia, PHA Board Director and Chair of PHA’s Medicaid Continuity & Quality Workgroup, which spearheaded the effort alongside Co-Chair, Leesa Allen, for the multi-stakeholder professional and trade association solely focused on population health management. Thank you to our experts panelists for conducting a comprehensive discussion on this vital matter and its far-reaching implications, which we are just beginning to surface.
|
|
Bill Lucia
Bill Lucia Associates, LLC
Healthcare and Digital Health Board Member and Advisor
|
|
Leesa Allen
Managing Director
Sellers Dorsey
|
|
Anthony Akosa, MD, MBA
System Medical Director of Care Management
Franciscan Alliance
|
|
David Grant
Chief Operating Officer
Keystone Health
|
|
Cheryl Friedman, RN, BSN MHA
Senior Vice President of Healthcare Services/ Population Health
Independent Health
|
|
“Medicaid agencies have begun the challenging task of redetermining eligibility for over 90 million individuals who are now covered under the Medicaid program. A significant number may no longer qualify for Medicaid and the effects of this will be far reaching and be felt across the health and human services sector,” explained Leesa Allen, Co-Chair of PHA’s Medicaid Workgroup, Managing Director of Sellers Dorsey and Former Department of Human Services Executive Deputy Secretary and Medicaid Director for the Commonwealth of Pennsylvania.
The 14-page report, entitled Medicaid Redetermination Getting it Right to Optimize Continuity and Care Outcomes, was a collaborative effort between the Population Health Alliance (PHA) and Sellers Dorsey. The report summarized the background of continuous eligibility, the predicted impacts to ending it, and opportunities for states, managed care organizations (MCOs), providers, and community-based organizations (CBOs) to assist individuals during this time of transition. Stay tuned for more updates as we will be closely monitoring this critical population health issue.
Listen to webinar recording by clicking here.
Download the whitepaper by clicking here.
|
|
Calling All Members: Contribute your Expertise by joining a PHA Work Group
While PHA has had a core group of members involved to date, we would like to engage additional perspectives from our membership, especially those focused on analytics, triage and outcomes. Please email staff@populationhealthalliance.org, if you would like to participate in one of the following workgroups: Advancing Primary Care, Medicaid Continuity and Quality, Social Care and Health Equity, and Behavioral Health. If you're not yet a PHA member, why not JOIN PHA NOW!
|
|
Take a look at some of the latest happenings from our PHA Members |
|
American College of Lifestyle Medicine announces recipients of national scholarship dedicated to reducing health disparities and diversifying the medical workforce
The American College of Lifestyle Medicine announced 18 awardees of its Health Equity Achieved Through Lifestyle Medicine (HEAL) Initiative Scholarship to support lifestyle medicine leaders who are working to reduce health disparities in historically underserved communities across the United States. In addition, the HEAL Scholarship Program is designed to support a diverse health care workforce by awarding underrepresented in medicine (UIM) clinicians with need-based scholarships that cover the costs associated with attaining education and certification in lifestyle medicine. This month, the nation observed National Minority Health Month and the importance of improving the health of underserved racial and ethnic communities, many of which UIM health care professionals and HEAL scholarship awardees serve. Read full story.
|
|
Blue Cross Blue Shield Association Applauds Bipartisan Transparent Billing Legislation from Reps. Kevin Hern (R-OK) and Annie Kuster (D-NH)
Blue Cross Blue Shield Association Senior Vice President of Policy and Advocacy David Merritt issued the following statement in response to the introduction of the Facility Accountability in Reimbursements Act by Reps. Kevin Hern (R-OK) and Annie Kuster (D-NH), which aims to ensure that patients are billed accurately based on the where they received care.
"No one should have to pay more for health care services based only on the location of care. This bipartisan, commonsense solution prioritizes the health and well-being of patients by promoting affordability, transparency and fairness. We are committed to advancing real solutions to improve care and lower costs for all Americans and look forward to working with Congress to pass this legislation as a critical step forward in achieving this goal.” Read full story.
|
|
CareOregon celebrates its first year with CareOregon Boys & Girls Club at Rockwood
CareOregon was honored last year to make a significant 10-year investment in the Boys & Girls Club of Portland Metropolitan Area—resulting in the organization’s Rockwood Club becoming the CareOregon Boys & Girls Club at Rockwood. Since then, they've worked together to help foster a stronger region for kids and families with an intentional focus on improving access to services and supports in Rockwood. With nearly half of Rockwood residents qualifying for the Oregon Health Plan—making it the highest concentration of OHP members in the region—this partnership aims to improve access to care and social health, while building community. Read full story.
|
|
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Novartis presents positive primary endpoint data from the pivotal Phase III NATALEE trial at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. Data showed that Kisqali® (ribociclib) plus endocrine therapy (ET), compared to ET alone, lowered the risk of cancer recurrence by 25.2% in patients with stage II and III hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) early breast cancer (HR=0.748; 95% CI: 0.618, 0.906; p=0.0014) along with a consistent, clinically meaningful invasive disease-free survival (iDFS) benefit across key pre-specified subgroups (see table below)1. Read full story.
|
|
Merck and Moderna Announce mRNA-4157 (V940) in Combination With KEYTRUDA® (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival (DMFS) in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus KEYTRUDA
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced distant metastasis-free survival (DMFS) results from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, in patients with resected high-risk melanoma (stage III/IV). Read full story.
|
|
UH Rainbow Babies & Children’s Hospital and Case Western Reserve University awarded NIH funding for neonatal care research
University Hospitals (UH) Rainbow Babies & Children’s Hospital (UH Rainbow) and Case Western Reserve University (CWRU) were selected by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to receive renewed funding to study newborn health through the Neonatal Research Network (NRN).
The NRN is a collaborative network of neonatal intensive care units across the United States, comprised of 15 elite clinical research centers and a data-coordinating center. Credited with laying the foundation for evidence-based care, the NRN has advanced outcomes in neonatal care for nearly four decades. Read full story.
|
|
Autonomous AI Prevents Blindness by Increasing Eye Exam for Diabetes Access for So-Cal Patients: White Paper
Digital Diagnostics- Autonomous artificial intelligence (AI) in healthcare is paving the way to achieve new breakthroughs in care for patients and providers while improving long term care outcomes. Tarzana Treatment Centers (TTC), a full-service primary and behavioral healthcare organization with several locations throughout the greater Los Angeles area, recently identified a way to increase care access for their 33,000 patients with complex medical needs by adopting LumineticsCore™ (formerly IDx-DR), an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy (including macular edema) Read full story.
|
|
Jefferson Investigates Discriminations Impact
Thomas Jefferson University-Moderate and severe traumatic brain injuries (TBIs) can lead to lifelong disability and require long-term medical care. While drugs and surgery can treat TBI, new research also shows that conditions in a patient’s life outside the doctor’s office — like educational level, economic status and neighborhood environment — can all play a role to help or hinder TBI recovery.
|
|
Bayer Launches Unit To Develop New Precision Health Consumer Products
The Consumer Health Division of Bayer has launched a business unit focused on developing new Precision Health products across its range of everyday health categories. Bayer will prioritize developing products that enable people to take greater control of their own personal health through digital solutions that facilitate more informed choices based on personal insights and novel delivery mechanisms.
The shift in the healthcare industry is clear, people need better self-care with the ability to predict, prevent and better manage their health. In fact, an analysis conducted for Bayer found over 80% of consumers globally already demand greater healthcare personalisation. Technology advancements have enabled a wave of new digital products such as diagnostics, apps and therapeutics to help them do so. Closing the gap between monitoring, awareness and diagnosis on one end and education, treatment and prevention on the other is the key to consumers being empowered to have end-to-end control over their own personal health. Read full story.
|
|
Porter Partners with Ixlayer To Close Care Gaps and Improve Patient Outcomes
Porter, a leading care coordination company, and ixlayer, the leading platform for health testing, recently announced a partnership to integrate ixlayer’s at-home testing and remote patient monitoring capabilities into Porter’s existing care coordination offerings. ixlayer will serve as the backbone of Porter’s infrastructure, enabling increased touchpoints during patient transitions from hospital to home, which will improve patient outcomes.
“By joining forces with Porter, we are breaking down silos and closing gaps in care, enabling increased access to remote lab testing and patient monitoring,” said Pouria Sanae, CEO and co-founder of ixlayer. “Together, we can help health plans increase HEDIS® measure compliance and positively influence consumer assessment survey results — and enable individuals and families to more easily access the care they need — by providing exceptional, best-in-class testing experiences.” Read full story.
|
|
i2i Population Health Successfully Completes NCQA’s Data Aggregator Validation Program
i2i Population Health, a leading provider of healthcare data aggregation solutions, is proud to announce its successful completion of the National Committee for Quality Assurance (NCQA)’s Data Aggregator Validation Program. This significant achievement further underscores i2i Population Health’s commitment to delivering high-quality and accurate healthcare data to its clients.
“We are thrilled to have completed the NCQA Data Aggregator Validation Program successfully,” said Justin Neece, CEO at i2i Population Health. “This accomplishment reinforces our dedication to excellence in healthcare data aggregation and further strengthens our position as a trusted partner for our clients. We are committed to providing accurate, secure, and interoperable data to support the healthcare industry’s evolving needs. Read full story.
|
|
Mars, Amcor, Delterra and P&G form strategic partnership to tackle plastic waste & develop circular economies in the Global South, commit $6 million
Mars, Amcor, Delterra and P&G jointly announce the launch of a strategic partnership to stem the tide of plastic pollution in the Global South. These global leaders will work together to scale upstream and downstream solutions for a circular plastics economy, jointly committing $6 million USD over five years.
The announcement comes in the lead-up to the second negotiating committee meeting for a Global Plastics Treaty (INC-2), working to develop a globally binding instrument on plastic pollution. The partners are coming together with a shared commitment to urgent environmental action and a shared understanding that the challenge of plastic pollution cannot be solved without a systemic and holistic approach to roll out scalable and sustainable programs to boost the transition to a circular economy. Read full story.
|
|
Franciscan Alliance Awarded Two State Tobacco Prevention And Cessation Grants
Franciscan Health Indianapolis- Franciscan Alliance is the recipient of two Indiana Department of Health Tobacco Prevention and Cessation division grants totaling $440,000 aimed at continuing and expanding the healthcare ministry's efforts. The awards include $300,000 for the next phase of the community-building partnership in Lake County and $140,000 for the continuation and expansion of a health systems change partnership at Franciscan Health Lafayette East.
"Franciscan Health is proud to partner with ISDH for a subsequent grant cycle to continue work on tobacco prevention and cessation initiatives within the health system and in multiple communities we serve," said Beth Segal, nursing manager for the Franciscan Healthy Living Center in Lafayette. "The teams involved with tobacco prevention and cessation work collaboratively to maximize the impact of the Franciscan Health ministry's efforts and to leverage the funding received to sustain change toward health improvements." Read full story.
|
|
Surgery Center at Geisinger Janet Weis Children’s Hospital Attains National Verification from the American College of Surgeons
The Geisinger Janet Weis Children’s Hospital surgical center has been verified as a Level II children’s surgery center by the American College of Surgeons Children’s Surgery Verification Quality Improvement Program.
“This is a tremendous honor and aligns with our commitment to provide optimal care for our children and families close to home across multiple surgical subspecialties,” said Alfred Kennedy, M.D., department chair of pediatric surgery. “The Children’s Surgery Verification Program specifically addresses the surgical care of infants and children and reinforces our work at Geisinger to have the right child with the right surgeon at the right time." Read full story.
|
|
Are you a PHA member with news to share?
We'd love to include it in this section!
|
|
A Special Thanks to PHA's Corporate Partners
|
|
|
|
|
|
|
